PULSE BIOSCIENCES, INC. — Director's Dealing 2022

Mar 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2022-02-14

Reporting Person: Danahy Kevin Patrick (Chief Commercial Office)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-14	Stock Option (right to buy)	$6.41	A	300000	Acquired	2032-02-14	Common Stock (300000)	Direct

Footnotes

F1: The option was granted on February 14, 2022 under the Issuer's 2017 Inducement Equity Incentive Plan. The shares subject to the option are subject to a mix of time-based and performance-based vesting criteria. 200,000 shares will vest in equal annual installments over the following four years on the anniversary of the grant date and 100,000 shares will vest in two equal annual installments on the third and fourth anniversaries of the grant date, in all cases, subject to the Reporting Person's continued service through each vesting date.

F2: Not applicable.